Stock Comparison

BEAM vs UNH

Beam Therapeutics Inc vs UnitedHealth Group Inc

The Verdict

BEAM takes this one.

Winner

BEAM

Beam Therapeutics Inc

9.1

out of 10

Hidden Gem

UNH

UnitedHealth Group Inc

0.3

out of 10

Distressed

Head-to-Head

$2.4B

Market Cap

$276.2B

0.0

P/E Ratio

22.9

-744.4%

Profit Margin

2.7%

-47.2%

Return on Equity

12.5%

0.2

Debt-to-Equity

0.0

Aggressive

Overall Risk

Moderate-High

9.1

DVR Score

0.3

The Deep Dive

BEAM9.1/10

Beam Therapeutics retains a high 10x growth potential, driven by its cutting-edge base editing platform, which continues to demonstrate significant promise for precision genetic cures. Recent positive developments, including the selection of an optimal dose for BEAM-302 in Phase 1/2 trials and the unveiling of the BEAM-304 PKU program (IND expected 2026), highlight strong execution and pipeline ex...

Full BEAM Analysis

UNH0.3/10

UnitedHealth Group (UNH) remains a healthcare titan, but its sheer scale and the highly regulated nature of its operations fundamentally limit its 10x growth potential within 3-5 years. The recent Optum Health operating loss of $278M in 2025 (compared to $7.77B income in 2024) is a significant concern, eroding the growth narrative that Optum once provided. Furthermore, the proposed 0.09% Medicare ...

Full UNH Analysis

Want More Comparisons?

Run any stock through our deep value analyzer.

Analyze Any Stock →

Not Financial Advice

This comparison is for educational purposes only. We are not financial advisors. Always do your own research and consult a qualified advisor before investing.